September 18, 2021

Volume XI, Number 261

Advertisement

September 17, 2021

Subscribe to Latest Legal News and Analysis

September 16, 2021

Subscribe to Latest Legal News and Analysis

September 15, 2021

Subscribe to Latest Legal News and Analysis

Applying for a License to Dispense Medical Cannabis in Alabama

Alabama became the 36th state to allow cannabis for medical use when Gov. Kay Ivey signed into law the Darren Wesley ‘Ato’ Hall Compassion Act on May 17, 2021. The act establishes a process through which applicants will compete for a limited number of licenses in the following categories: (1) cultivator; (2) processor; (3) dispensary; and (4) “integrated facility” (which can cultivate, process, transport, and dispense medical cannabis under one license), as well as a to-be-determined number of licenses for secure transporters and testing laboratories. A 14-member Medical Cannabis Commission licenses and regulates the medical cannabis program, with input from the Alabama Department of Agriculture and Industries on cultivation matters. The act requires that the Commission and the department adopt regulations that allow license applications by September 1, 2022.

This article provides an overview of the requirements for obtaining a dispensary license, and is part of a series of similar overviews for the other five license categories. 

What is a dispensary license?

A dispensary license authorizes the licensee to: (1) purchase and transfer cannabis from a processor, integrated facility, or cultivator, if the cultivator contracted with a processor to process its cannabis on the cultivator’s behalf; and (2) dispense and sell medical cannabis to a registered qualified patient or registered caregiver.

How many dispensary licenses will be issued?

The act authorizes the Commission to issue four dispensary licenses. At least one license must be awarded to a business entity that is 51%+ owned by individuals of “African American, Native American, Asian, or Hispanic descent,” and “managed and controlled” by such individuals “in its daily operations.” Each dispensary licensee may operate up to three dispensing sites, each of which must be in a different county from any other dispensing site and is subject to other restrictions.

What are the requirements for obtaining a dispensary license?

Applicants for a dispensary license must pay a non-refundable application fee of $2,500. Each “owner, shareholder, director, [and] board member” of an applicant, along with each “individual with an economic interest in an applicant,” must submit to a “state and national criminal background check.” If any “owner, director, board member, or individual with a controlling interest” has been “convicted of or released from incarceration for [any] felony” or “convicted of a controlled substance-related felony” within the last 10 years, the applicant is ineligible for a license.

The act requires that applicants include a bevy of information in their applications, including:

  • The identity of all individuals with “direct or indirect ownership interests” in the applicant.

  • The identity of entities that are involved in the cannabis industry and related to the applicant or individuals with an ownership interest in the applicant.

  • A complete criminal history of the applicant’s owners, directors, board members, and controlling shareholders.

  • The applicant’s anticipated or actual number of employees.

  • “Financial information” in the “manner and form” required by the Commission.

  • Records indicating “that a majority of ownership is attributable to an individual or individuals with proof of [Alabama] residence … for a continuous period of no less than 15 years preceding the application date.”

Under the act, licensees must maintain at least $2 million in “liability and casualty insurance” coverage, and the Commission may promulgate regulations that “establish minimum levels of other financial guarantees” that licensees must maintain. If an applicant fails to demonstrate its ability to meet these requirements, it cannot receive a license.

The act lists numerous criteria the Commission may use to evaluate license applications, including:

  • The applicant’s “ability to capitalize and conduct operations as proposed in its business plan, including business experience in related fields.”

  • Several other criteria aimed at the applicant’s financial backing and business acumen.

  • Any history of non-compliance with any regulatory requirements.

  • That the applicant’s “proposed location[s] of all proposed medical cannabis facilities” are “suitable for all activities” and “not inconsistent with applicable zoning.”

  • The applicant’s “ability to serve an identifiable geographic area.”

Before issuing a license, the Commission must open a 30-day period during which anyone can submit “written comments regarding the applicant,” and the Commission is required to consider all comments received. If an applicant is denied a license, it can request that the Commission “provide a public investigative hearing at which the applicant is given the opportunity to present testimony and evidence to establish its suitability for a license.” The Commission must provide such a hearing upon request.

Each applicant (for all license types) must certify in its application that it “does not have an economic interest in any other [Alabama medical cannabis] license.” Licenses and ownership interests in licensed entities cannot be transferred absent approval by the Commission.

How competitive is the licensing process?

Alabama is not the first state to adopt a “limited license” regime for state-legal cannabis, and the experiences of predecessor states (including neighboring Florida) show the fight for licenses will be extremely competitive. Some of the most well-established cannabis operators in the country (and the world) will be applying for a small number of Alabama licenses. Further, the evaluation criteria for license applicants is largely subjective, and the evaluation process ensures that obtaining a license will be a question, in part, of influence.

© 2021 Bradley Arant Boult Cummings LLPNational Law Review, Volume XI, Number 209
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

James W. Wright Jr. Attorney Banking Financial Services Bradley Arant Boult Cummings Birmingham
Partner

Jay Wright is a partner in the firm’s Banking and Financial Services and Litigation practice groups. Jay has earned his Accredited Mortgage Professional (AMP) designation through the Mortgage Bankers Association (MBA), and is one of a small number of lawyers who have achieved this status.

Jay’s practice focuses on financial services litigation and regulation, and he is actively involved in lawsuits and disputes across the country representing companies involved in a wide array of state and federal law claims. His representation includes general...

205-521-8924
Whitt Steineker Cannabis Attorney Bradley Birmingham
Partner

Whitt Steineker has devoted his legal career to representing companies that provide a wide range of goods and services. He provides clients of all types with litigation counsel, transactional advice, and practical strategies for growth. Whitt advises clients of all sizes—from multinational corporations to local businesses—in transactional and litigation matters in jurisdictions across the country and around the world.

As co-chair of Bradley’s Cannabis Industry team, Whitt represents clients on a wide range of cannabis issues. In addition to...

205-521-8401
Advertisement
Advertisement
Advertisement